1. Witt, P. L., Lindner, D. J., D’ Cunha, J., and Borden, E. C. (1996) Pharmacology of interferons: induced proteins, cell activation, and antitumor activity, in Cancer Chemotherapy and Biotherapy ( Chabner, B. A. and Longo, D. L., eds.), Lippincott-Raven, Philadelphia, PA, pp. 585–607.
2. Gutterman, J. U., Fine, S., Quesada, S., et al. (1982) Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann. Intern. Med. 96, 549.
3. Nagata, S., Mantei, N., and Weissmann, C. (1980) Structure of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 287, 401.
4. Streuli, M., Nagata, S., and Weissman, C. (1980) At least three human type alpha interferons: structure of alpha 2. Science 209, 1343.
5. Merlin, G., Falcoff, E., and Aguet, M. (1985) 125I-labelled human inter-ferons alpha, beta and gamma: comparative receptor-binding data. J. Gen. Virol. 66, 1149.